Andrew M Evens

35PUBLICATIONS
178CO-AUTHORS
Haematological tumoursFoetal development and medicineLiquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jul 29, 2026
Impact of EBV Status and Histology on Patient Outcomes with Nivolumab-AVD vs BV-AVD in Advanced Classic Hodgkin Lymphoma (S1826).

|Apr 24, 2026
Expert Opinion on the Diagnosis and Treatment of Hematologic Malignancies During Pregnancy.

|Jan 09, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826.

Sharon M Castellino, Hongli Li, Alex F Herrera

|Jun 16, 2025
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.

Sarah C Rutherford, Hongli Li, Alex F Herrera

|Feb 20, 2025
Perspectives of Lymphoma Survivors and Oncology Care Providers on Survivorship Care: A Qualitative Study.

Jeanne M Ferrante, Myneka Macenat, Jenna Howard

|Oct 16, 2024
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.

Alex F Herrera, Michael LeBlanc, Sharon M Castellino

Pageof 6

Frequent Collaborators

8 joint publications

Susan K Parsons

5 joint publications

Narendranath Epperla

5 joint publications

Pallawi Torka

4 joint publications

Umar Farooq